导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 5.33% | 369/1050 |
| 近一周 | -1.57% | 246/1104 |
| 近一月 | -1.77% | 198/1102 |
| 近一季 | -5.85% | 460/1092 |
| 近半年 | 4.21% | 330/1070 |
| 近一年 | 9.55% | 359/1018 |
| 近两年 | 59.01% | 437/926 |
| 近三年 | 44.98% | 291/834 |
| 成立以来 | 93.39% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-2.30% 669/1070 |
19.17% 393/1101 |
- - |
- - |
| 2025 | 23.24% 614/1065 |
0.37% 772/1014 |
3.99% 360/1038 |
16.03% 726/1050 |
1.77% 328/1065 |
| 2024 | 16.82% 134/1011 |
2.51% 187/960 |
0.40% 278/983 |
14.15% 290/991 |
-0.57% 352/1011 |
| 2023 | -6.49% 238/952 |
3.83% 385/880 |
-2.24% 319/895 |
-3.06% 204/915 |
-4.97% 497/952 |
| 2022 | -22.55% 426/867 |
-13.37% 191/773 |
6.30% 447/806 |
-11.90% 381/845 |
-4.54% 625/867 |
| 2021 | 5.58% 294/740 |
-2.58% 246/580 |
9.44% 375/659 |
-1.60% 247/704 |
0.64% 412/740 |
| 2020 | 47.69% 248/554 |
-5.74% 310/419 |
20.32% 280/466 |
16.14% 125/517 |
12.13% 288/554 |
| 2019 | - - |
- - |
- - |
1.21% 300/390 |
9.49% 174/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 博道叁佰智航股票A VS. 东吴新产业精选股票A(580008) |